Serge Belanger Analyst Performance

Senior Analyst at Needham & Company LLC

Serge Belanger is a stock analyst at Needham & Company LLC in the medical sector, covering 23 publicly traded companies. Over the past year, Serge Belanger has issued 79 stock ratings, including buy and hold recommendations. While full access to Serge Belanger's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Serge Belanger's coverage history, rating activity, and performance tendencies â€” helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 202 Last 11 Years
Buy Recommendations: 88.61% 179 Buy Ratings
Companies Covered: 23 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	88.6%	179 ratings
Hold	11.4%	23 ratings
Sell	0.0%	0 ratings

Out of 202 total stock ratings issued by Serge Belanger at Needham & Company LLC, the majority (88.6%) have been Buy recommendations, followed by 11.4% Hold.

Best & Worst Calls

Best Call
0000.0%
LQDA
May 2025
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
0000.0%
CRXTQ
Mar 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	95.7% of companies on NASDAQ	22 companies
OTCMKTS	4.3% of companies on OTCMKTS	1 company

Serge Belanger, an analyst at Needham & Company LLC, currently covers 23 companies listed on NASDAQ and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 23 companies	100.0%

Serge Belanger of Needham & Company LLC specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 11 companies	47.8%
MED - DRUGS 9 companies	39.1%
MED PRODUCTS 2 companies	8.7%
MED - GENERIC DRG 1 company	4.3%

About Serge Belanger

Serge Belanger joined Needham & Company in 2009, where he covers the Biotechnology sector. Prior to Needham, Serge worked as a research associate at Fulcrum Global Partners and Susquehanna International Group covering the biotech and specialty pharma healthcare sectors. Previously, Serge was part of Adolor Corporation, a biopharmaceutical company, as a senior research scientist, where he was involved with the discovery and development of novel opioid receptor targeted molecules and non-opioid pain therapeutics. Serge graduated from McGill University with a BSc, Biochemistry/Pharmacology, and an MSc, Pharmacology and Therapeutics. He obtained his MBA in Finance from the Stern School of Business at New York University.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
TRVI Trevi Therapeutics	5/20/2026	Reiterated Rating	$13.77	$23.00	Buy
MLTX MoonLake Immunotherapeutics	5/12/2026	Boost Price Target	$18.84	$30.00	Buy
OCS Oculis	5/12/2026	Boost Price Target	$30.40	$46.00	Buy
LQDA Liquidia	5/11/2026	Boost Price Target	$52.61	$70.00	Buy
XENE Xenon Pharmaceuticals	5/8/2026	Lower Price Target	$56.00	$78.00	Buy
AMPH Amphastar Pharmaceuticals	5/8/2026	Reiterated Rating	$24.03		Hold
ARQT Arcutis Biotherapeutics	5/7/2026	Reiterated Rating	$24.17	$36.00	Buy
TRVI Trevi Therapeutics	5/6/2026	Lower Price Target	$14.66	$23.00	Buy
BCRX BioCryst Pharmaceuticals	5/6/2026	Lower Price Target	$8.86	$16.00	Buy
VRDN Viridian Therapeutics	5/5/2026	Reiterated Rating	$18.77	$32.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
OCUL Ocular Therapeutix	5/5/2026	Reiterated Rating	$9.71	$18.00	Buy
CYTK Cytokinetics	5/5/2026	Boost Price Target	$77.20	$102.00	Buy
ESPR Esperion Therapeutics	5/4/2026	Downgrade	$3.12		Hold
PCRX Pacira BioSciences	5/1/2026	Boost Price Target	$25.49	$32.00	Buy
KALV KalVista Pharmaceuticals	4/30/2026	Downgrade	$26.66		Hold
CRMD CorMedix	4/27/2026	Boost Price Target	$7.54	$15.00	Buy
VRDN Viridian Therapeutics	3/30/2026	Lower Price Target	$18.52	$32.00	Buy
KALV KalVista Pharmaceuticals	3/25/2026	Boost Price Target	$17.14	$36.00	Buy
COLL Collegium Pharmaceutical	3/19/2026	Reiterated Rating	$36.30	$56.00	Buy
TRVI Trevi Therapeutics	3/18/2026	Boost Price Target	$11.19	$24.00	Buy
XENE Xenon Pharmaceuticals	3/9/2026	Boost Price Target	$61.46	$80.00	Buy
LQDA Liquidia	3/5/2026	Boost Price Target	$34.52	$54.00	Buy
CRMD CorMedix	3/5/2026	Lower Price Target	$6.30	$14.00	Buy
OCS Oculis	3/4/2026	Boost Price Target	$27.57	$40.00	Buy
ESPR Esperion Therapeutics	3/3/2026	Boost Price Target	$2.94	$5.00	Buy
AMPH Amphastar Pharmaceuticals	2/27/2026	Lower Price Target	$26.49	$30.00	Buy
XENE Xenon Pharmaceuticals	2/27/2026	Boost Price Target	$42.23	$58.00	Buy
ARQT Arcutis Biotherapeutics	2/26/2026	Boost Price Target	$27.01	$36.00	Buy
COLL Collegium Pharmaceutical	2/26/2026	Lower Price Target	$44.01	$54.00	Buy
CYTK Cytokinetics	2/25/2026	Boost Price Target	$70.10	$85.00	Buy
LQDA Liquidia	2/25/2026	Reiterated Rating	$30.16	$52.00	Buy
MLTX MoonLake Immunotherapeutics	2/23/2026	Boost Price Target	$18.68	$25.00	Buy
OCUL Ocular Therapeutix	2/20/2026	Lower Price Target	$7.03	$18.00	Buy
NAMS NewAmsterdam Pharma	2/18/2026	Boost Price Target	$36.41	$48.00	Buy
VRDN Viridian Therapeutics	2/4/2026	Reiterated Rating	$31.90	$42.00	Buy
ARQT Arcutis Biotherapeutics	1/26/2026	Boost Price Target	$26.29	$31.00	Buy
PCRX Pacira BioSciences	1/9/2026	Reiterated Rating	$26.02	$30.00	Buy
CRMD CorMedix	1/8/2026	Lower Price Target	$7.51	$15.00	Buy
COLL Collegium Pharmaceutical	1/8/2026	Boost Price Target	$48.78	$56.00	Buy
KALV KalVista Pharmaceuticals	1/6/2026	Boost Price Target	$15.66	$32.00	Buy
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad) Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500. See how to get positioned in SpaceX before the announcement goes public
EOLS Evolus	12/24/2025	Reiterated Rating	$6.81		Hold
VRDN Viridian Therapeutics	12/23/2025	Boost Price Target	$32.47	$42.00	Buy
CYTK Cytokinetics	12/22/2025	Boost Price Target	$62.72	$84.00	Buy
CYTK Cytokinetics	12/12/2025	Reiterated Rating	$60.77	$72.00	Buy
OCUL Ocular Therapeutix	12/8/2025	Reiterated Rating	$15.95	$20.00	Buy
KALV KalVista Pharmaceuticals	12/4/2025	Reiterated Rating	$14.66	$28.00	Buy
CLSD Clearside Biomedical	11/18/2025	Reiterated Rating	$3.32		Hold
CRMD CorMedix	11/12/2025	Lower Price Target	$11.17	$16.00	Buy
OCS Oculis	11/11/2025	Reiterated Rating	$19.42	$36.00	Buy
AMPH Amphastar Pharmaceuticals	11/7/2025	Lower Price Target	$24.23	$34.00	Buy
NAMS NewAmsterdam Pharma	11/5/2025	Boost Price Target	$39.84	$46.00	Buy
BCRX BioCryst Pharmaceuticals	11/4/2025	Lower Price Target	$6.86	$18.00	Buy
LQDA Liquidia	11/4/2025	Boost Price Target	$25.22	$52.00	Buy
XENE Xenon Pharmaceuticals	11/4/2025	Reiterated Rating	$41.12	$55.00	Buy
COLL Collegium Pharmaceutical	10/28/2025	Reiterated Rating	$34.81	$46.00	Buy
ARQT Arcutis Biotherapeutics	10/28/2025	Boost Price Target	$24.95	$30.00	Buy
AMPH Amphastar Pharmaceuticals	10/22/2025	Reiterated Rating	$24.26	$36.00	Buy
BCRX BioCryst Pharmaceuticals	10/15/2025	Boost Price Target	$6.42	$20.00	Buy
OMER Omeros	10/15/2025	Reiterated Rating	$10.94		Hold
OCUL Ocular Therapeutix	10/1/2025	Boost Price Target	$11.11	$20.00	Buy
MLTX MoonLake Immunotherapeutics	9/30/2025	Lower Price Target	$6.24	$20.00	Buy
KALV KalVista Pharmaceuticals	9/12/2025	Reiterated Rating	$13.60	$28.00	Buy
CYTK Cytokinetics	9/2/2025	Reiterated Rating	$35.33	$72.00	Buy
OCS Oculis	8/27/2025	Initiated Coverage	$17.53	$36.00	Buy
OMER Omeros	8/15/2025	Reiterated Rating	$4.12		Hold
AMPH Amphastar Pharmaceuticals	8/12/2025	Upgrade	$27.36	$36.00	Buy
LQDA Liquidia	8/12/2025	Boost Price Target	$24.10	$36.00	Buy
TRVI Trevi Therapeutics	8/8/2025	Lower Price Target	$7.30	$22.00	Buy
HRTX Heron Therapeutics	8/8/2025	Lower Price Target	$1.33	$3.00	Buy
ARQT Arcutis Biotherapeutics	8/7/2025	Boost Price Target	$15.36	$22.00	Buy
VRDN Viridian Therapeutics	8/6/2025	Lower Price Target	$17.22	$34.00	Buy
EOLS Evolus	8/6/2025	Reiterated Rating	$8.91	$22.00	Hold
OCUL Ocular Therapeutix	8/5/2025	Boost Price Target	$12.00	$15.00	Buy
BCRX BioCryst Pharmaceuticals	8/4/2025	Reiterated Rating	$8.73	$17.00	Buy
CLSD Clearside Biomedical	7/17/2025	Downgrade	$9.12	$45.00	Hold
BCRX BioCryst Pharmaceuticals	6/25/2025	Reiterated Rating	$9.78	$17.00	Buy
CRMD CorMedix	6/24/2025	Boost Price Target	$16.56	$20.00	Buy
NAMS NewAmsterdam Pharma	6/12/2025	Reiterated Rating	$20.50	$40.00	Buy
LQDA Liquidia	5/28/2025	Reiterated Rating	$15.60	$25.00	Buy
ARQT Arcutis Biotherapeutics	5/23/2025	Reiterated Rating	$13.66	$20.00	Buy
LQDA Liquidia	5/21/2025	Reiterated Rating	$17.02	$25.00	Buy
TRVI Trevi Therapeutics	5/20/2025	Reiterated Rating	$6.49	$24.00	Buy
VRDN Viridian Therapeutics	5/20/2025	Reiterated Rating	$13.25	$36.00	Buy
OMER Omeros	5/16/2025	Reiterated Rating	$3.95		Hold
CLSD Clearside Biomedical	5/15/2025	Lower Price Target	$12.81	$45.00	Buy
CYTK Cytokinetics	5/14/2025	Reiterated Rating	$30.61	$72.00	Buy
VRCA Verrica Pharmaceuticals	5/14/2025	Reiterated Rating	$0.50		Hold
XENE Xenon Pharmaceuticals	5/13/2025	Lower Price Target	$35.85	$55.00	Buy
MLTX MoonLake Immunotherapeutics	5/13/2025	Reiterated Rating	$40.18	$66.00	Buy
LQDA Liquidia	5/12/2025	Reiterated Rating	$15.93	$25.00	Buy
Elon Musk’s $1 Quadrillion AI IPO (Ad) $1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today. Claim Your Stake Now
PCRX Pacira BioSciences	5/9/2025	Lower Price Target	$24.90	$30.00	Buy
EOLS Evolus	5/8/2025	Reiterated Rating	$11.80	$22.00	Buy
NAMS NewAmsterdam Pharma	5/8/2025	Lower Price Target	$19.50	$40.00	Buy
VRDN Viridian Therapeutics	5/7/2025	Lower Price Target	$12.03	$36.00	Buy
CRMD CorMedix	5/7/2025	Boost Price Target	$11.16	$15.00	Buy
ESPR Esperion Therapeutics	5/7/2025	Lower Price Target	$0.98	$4.00	Buy
BCRX BioCryst Pharmaceuticals	5/6/2025	Boost Price Target	$11.03	$17.00	Buy
CYTK Cytokinetics	5/2/2025	Reiterated Rating	$42.92	$72.00	Buy
MLTX MoonLake Immunotherapeutics	4/30/2025	Reiterated Rating	$40.18	$66.00	Buy
ESPR Esperion Therapeutics	4/25/2025	Reiterated Rating	$0.88	$5.00	Buy
HRTX Heron Therapeutics	4/11/2025	Reiterated Rating	$1.82	$4.00	Buy
BCRX BioCryst Pharmaceuticals	4/10/2025	Reiterated Rating	$6.77	$15.00	Buy
LQDA Liquidia	4/10/2025	Reiterated Rating	$12.77	$25.00	Buy
AMPH Amphastar Pharmaceuticals	4/10/2025	Reiterated Rating	$25.23		Hold
ARQT Arcutis Biotherapeutics	4/9/2025	Reiterated Rating	$13.29	$20.00	Buy
VRCA Verrica Pharmaceuticals	4/9/2025	Reiterated Rating	$0.58		Hold
EOLS Evolus	4/9/2025	Reiterated Rating	$9.36	$22.00	Buy
CRMD CorMedix	4/9/2025	Reiterated Rating	$6.79	$12.00	Buy
KALV KalVista Pharmaceuticals	4/8/2025	Reiterated Rating	$11.50	$28.00	Buy
TRVI Trevi Therapeutics	4/8/2025	Reiterated Rating	$5.78	$24.00	Buy
CYTK Cytokinetics	4/8/2025	Reiterated Rating	$35.99	$72.00	Buy
ESPR Esperion Therapeutics	4/8/2025	Reiterated Rating	$1.20	$5.00	Buy
CLSD Clearside Biomedical	4/8/2025	Reiterated Rating	$12.68	$60.00	Buy
NAMS NewAmsterdam Pharma	4/8/2025	Reiterated Rating	$15.86	$42.00	Buy
PCRX Pacira BioSciences	4/8/2025	Reiterated Rating	$22.91	$32.00	Buy
ARQT Arcutis Biotherapeutics	4/3/2025	Reiterated Rating	$16.60	$20.00	Buy
OMER Omeros	4/1/2025	Reiterated Rating	$8.27		Hold
CLSD Clearside Biomedical	3/28/2025	Lower Price Target	$15.45	$60.00	Buy
CRMD CorMedix	3/26/2025	Lower Price Target	$7.34	$12.00	Buy
KALV KalVista Pharmaceuticals	3/26/2025	Reiterated Rating	$12.07	$28.00	Buy
LQDA Liquidia	3/20/2025	Boost Price Target	$14.92	$25.00	Buy
TRVI Trevi Therapeutics	3/19/2025	Lower Price Target	$6.56	$24.00	Buy
KALV KalVista Pharmaceuticals	3/13/2025	Reiterated Rating	$12.45	$28.00	Buy
OCUL Ocular Therapeutix	3/11/2025	Initiated Coverage	$7.65	$15.00	Buy
TRVI Trevi Therapeutics	3/10/2025	Boost Price Target	$4.30	$25.00	Buy
CLSD Clearside Biomedical	3/6/2025	Reiterated Rating	$14.40	$90.00	Buy
EOLS Evolus	3/5/2025	Reiterated Rating	$14.35	$22.00	Buy
PCRX Pacira BioSciences	2/28/2025	Boost Price Target	$25.38	$32.00	Buy
HRTX Heron Therapeutics	2/28/2025	Reiterated Rating	$2.05	$4.00	Buy
MLTX MoonLake Immunotherapeutics	2/27/2025	Boost Price Target	$42.37	$66.00	Buy
ARQT Arcutis Biotherapeutics	2/26/2025	Reiterated Rating	$12.20	$20.00	Buy
CYTK Cytokinetics	2/6/2025	Reiterated Rating	$46.44	$72.00	Buy
EOLS Evolus	1/21/2025	Reiterated Rating	$13.87	$22.00	Buy
OMER Omeros	1/17/2025	Reiterated Rating	$9.18		Hold
BCRX BioCryst Pharmaceuticals	1/13/2025	Boost Price Target	$7.67	$15.00	Buy
PCRX Pacira BioSciences	1/13/2025	Boost Price Target	$20.64	$30.00	Buy

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.